Literature DB >> 15163780

Prostate cancers in men with low PSA levels--must we find them?

H Ballentine Carter.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15163780      PMCID： PMC3474980          DOI： 10.1056/NEJMe048003

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  18 in total

1.  Implications of stage-specific survival rates in assessing recent declines in prostate cancer mortality rates.

Authors:  R E Tarone; K C Chu; O W Brawley
Journal:  Epidemiology       Date:  2000-03       Impact factor: 4.822

2.  Clinical evidence for and implications of the multistep development of prostate cancer.

Authors:  H B Carter; S Piantadosi; J T Isaacs
Journal:  J Urol       Date:  1990-04       Impact factor: 7.450

3.  Trends in prostate cancer mortality among black men and white men in the United States.

Authors:  Kenneth C Chu; Robert E Tarone; Harold P Freeman
Journal:  Cancer       Date:  2003-03-15       Impact factor: 6.860

4.  Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia.

Authors:  A W Partin; H B Carter; D W Chan; J I Epstein; J E Oesterling; R C Rock; J P Weber; P C Walsh
Journal:  J Urol       Date:  1990-04       Impact factor: 7.450

5.  Cancer surveillance series: interpreting trends in prostate cancer--part II: Cause of death misclassification and the recent rise and fall in prostate cancer mortality.

Authors:  E J Feuer; R M Merrill; B F Hankey
Journal:  J Natl Cancer Inst       Date:  1999-06-16       Impact factor: 13.506

6.  Serendipity in detecting disease in low prostate-specific antigen ranges.

Authors:  A N Vis; R Kranse; M Roobol; Th H van der Kwast; F H Schröder
Journal:  BJU Int       Date:  2002-03       Impact factor: 5.588

7.  Patterns of progression in prostate cancer.

Authors:  J E McNeal; D G Bostwick; R A Kindrachuk; E A Redwine; F S Freiha; T A Stamey
Journal:  Lancet       Date:  1986-01-11       Impact factor: 79.321

8.  Long-term cancer control of radical prostatectomy in men younger than 50 years of age: update 2003.

Authors:  Masood A Khan; Misop Han; Alan W Partin; Jonathan I Epstein; Patrick C Walsh
Journal:  Urology       Date:  2003-07       Impact factor: 2.649

9.  Enthusiasm for cancer screening in the United States.

Authors:  Lisa M Schwartz; Steven Woloshin; Floyd J Fowler; H Gilbert Welch
Journal:  JAMA       Date:  2004-01-07       Impact factor: 56.272

10.  Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter.

Authors:  Ian M Thompson; Donna K Pauler; Phyllis J Goodman; Catherine M Tangen; M Scott Lucia; Howard L Parnes; Lori M Minasian; Leslie G Ford; Scott M Lippman; E David Crawford; John J Crowley; Charles A Coltman
Journal:  N Engl J Med       Date:  2004-05-27       Impact factor: 91.245
View more
  18 in total

1.  Screening for coronary heart disease: cardiology through the oncology looking glass.

Authors:  D Douglas Miller; Leslee J Shaw
Journal:  J Nucl Cardiol       Date:  2005 Mar-Apr       Impact factor: 5.952

2.  Detecting Prostate Cancer with Molecular Markers: uPM3.

Authors:  Stephen J Freedland; Alan W Partin
Journal:  Rev Urol       Date:  2005

3.  Translation research in prostate cancer.

Authors:  Danil V Makarov; Alan W Partin
Journal:  Rev Urol       Date:  2006

4.  Distribution of PSA velocity by total PSA levels: data from the Baltimore Longitudinal Study of Aging.

Authors:  Stacy Loeb; H Ballentine Carter; Edward M Schaeffer; Anna Kettermann; Luigi Ferrucci; E Jeffrey Metter
Journal:  Urology       Date:  2011-01       Impact factor: 2.649

Review 5.  Cancer diagnosis in primary care.

Authors:  William Hamilton
Journal:  Br J Gen Pract       Date:  2010-02       Impact factor: 5.386

6.  Detection of life-threatening prostate cancer with prostate-specific antigen velocity during a window of curability.

Authors:  H Ballentine Carter; Luigi Ferrucci; Anna Kettermann; Patricia Landis; E James Wright; Jonathan I Epstein; Bruce J Trock; E Jeffrey Metter
Journal:  J Natl Cancer Inst       Date:  2006-11-01       Impact factor: 13.506

7.  Pathologic characteristics of cancers detected in The Prostate Cancer Prevention Trial: implications for prostate cancer detection and chemoprevention.

Authors:  M Scott Lucia; Amy K Darke; Phyllis J Goodman; Francisco G La Rosa; Howard L Parnes; Leslie G Ford; Charles A Coltman; Ian M Thompson
Journal:  Cancer Prev Res (Phila)       Date:  2008-05-18

8.  A Review on the Clinical Utility of PSA in Cancer Prostate.

Authors:  Mohan Adhyam; Anish Kumar Gupta
Journal:  Indian J Surg Oncol       Date:  2012-03-03

9.  Applying strategies from libertarian paternalism to decision making for prostate specific antigen (PSA) screening.

Authors:  David C Wheeler; Konrad M Szymanski; Amanda Black; David E Nelson
Journal:  BMC Cancer       Date:  2011-04-21       Impact factor: 4.430

10.  Accuracy of a high prostate-specific antigen level for prostate cancer diagnosis upon initial biopsy in Korean men.

Authors:  Hong Bang Shim; Sang Eun Lee; Hyoung Keun Park; Ja Hyeon Ku
Journal:  Yonsei Med J       Date:  2007-08-31       Impact factor: 2.759
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.